Elite Pharmaceuticals
researches, develops, licenses and manufactures oral controlled-release pharmaceutical products... Read moreElite Pharmaceuticals
researches, develops, licenses and manufactures oral controlled-release pharmaceutical products... Read more
News
Feb 20, 2026
Zacks
Elite Pharmaceuticals: Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump
Feb 18, 2026
Owler
Elite Pharmaceuticals Inc: Elite Pharmaceuticals's revenue changed from $122.89M in Sep 2025 to $139.91M in Dec 2025
Feb 17, 2026
Seeking Alpha
Elite Pharmaceuticals: Elite Pharmaceuticals GAAP EPS of $0.01, revenue of $31.6M
Nov 19, 2025
Yahoo
Elite Pharmaceuticals: ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
Nov 15, 2025
Owler
Elite Pharmaceuticals Inc: Elite Pharmaceuticals's revenue changed from $105.45M in Jun 2025 to $122.89M in Sep 2025
Aug 21, 2025
Yahoo
Elite Pharmaceuticals: ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth
Aug 15, 2025
Seeking Alpha
Elite Pharmaceuticals: Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M
Jul 03, 2025
Zacks
Elite Pharmaceuticals: Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump
Jun 30, 2025
FinanzNachrichten
Elite Pharmaceuticals: Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information
Jun 16, 2025
StreetInsider
Press Release: Elite Pharmaceuticals : Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Elite Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10